Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | USP2 | O75604 | 3/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | BLM | P54132 | 3/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | RGS12 | O14924 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5320318 | 1.00 | KDM4E (0.54) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL10884344 | 0.90 | LMNA (0.45) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL5287555 | 0.88 | KDM4E (0.53) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL25471322 | 0.85 | KDM4E (0.54) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL9847960 | 0.84 | KDM4E (0.49) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL9847929 | 0.83 | KDM4E (0.47) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL20357995 | 0.83 | KDM4E (0.47) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL25167472 | 0.82 | THRB (0.46) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| Salicylic Acid SCHEMBL935529 | 0.80 | KDM4E (0.40) | KDM4EUSP2HIF1AALOX15HSD17B10 | |
| SCHEMBL454801 | 0.79 | KDM4E (0.58) | KDM4EUSP2HIF1AALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109988312-B | Polyamide acid ester, preparation method, negative polyimide composition and application | 深圳先进技术研究院 | 2023-04-11 | — | — | CN | claimed |
| CN-109988312-A | A kind of poly amic acid ester, preparation method and negative polyimide composition and application | 深圳先进技术研究院 | 2019-07-09 | — | — | CN | claimed |
| CN-109946925-A | A kind of compound is promoting the application in polyimides low-temperature setting, polyimide precursor composition and application thereof | 深圳先进技术研究院 | 2019-06-28 | — | — | CN | claimed |
| CN-105420203-A | Tyrosine analogue translation system and gene-encoded protein photoinduced electron transfer fluorescence sensor protein family | INST OF BIOPHYSICS CHINESE ACAD OF SCIENCES | 2016-03-23 | — | — | CN | claimed |
| EP-1856274-B1 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | CLEVELAND CLINIC FOUNDATION (US) | 2014-08-27 | — | — | EP | claimed |
| CN-103228675-A | Composition, antibody, asthma diagnosis method and method for preparing antibody | BATTELLE MEMORIAL INSTITUTE | 2013-07-31 | — | — | CN | claimed |
| US-20110165594-A1 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2011-07-07 | — | — | US | claimed |
| EP-1856274-A2 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2007-11-21 | — | — | EP | claimed |
| US-20060211079-A1 | Systemic markers for asthma and analogous diseases | THE CLEVELAND CLINIC FOUNDATION | 2006-09-21 | — | — | US | claimed |
| WO-2006091403-A2 | SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES | THE CLEVELAND CLINIC FOUNDATION (US) | 2006-08-31 | — | — | WO | claimed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | claimed |
| US-12084614-B2 | Akaline scale mitigation treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-09-10 | — | — | US | disclosed |
| US-12084613-B2 | Oil/gas pipeline treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-09-10 | — | — | US | disclosed |
| US-12031086-B1 | Well sulfatizing and scale mitigation treatment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-09 | — | — | US | disclosed |
| US-20240218238-A1 | AKALINE SCALE MITIGATION TREATMENT METHOD | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-07-04 | — | — | US | disclosed |
| US-20060024724-A1 | Oncofetal fibronectin as a marker for health and disease | CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-20060024725-A1 | Oncofetal fibronectin as a marker for pregnancy-related indications | THIRD WAVE TECHNOLOGIES, INC. | 2006-02-02 | — | — | US | disclosed |
| US-20060024757-A1 | Detection of oncofetal fibronectin for selection of concepti | CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP | 2006-02-02 | — | — | US | disclosed |
| US-20060024722-A1 | Samples for detection of oncofetal fibronectin and uses thereof | BIOLUCENT, LLC | 2006-02-02 | — | — | US | disclosed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | disclosed |